Incidence and risk factors for dermatologic adverse events following apalutamide use: a real-world data analysis in the Korean population
dAEs are prevalent in Korean patients treated with apalutamide for mHSPC, with ECOG-PS and serum albumin levels identified as significant risk factors.
Authors
- Jungyo Suh (ORCID: https://orcid.org/0000-0002-3867-4778)
- Bumjin Lim (ORCID: https://orcid.org/0000-0002-1746-6072)
- In Gab Jeong (ORCID: https://orcid.org/0000-0003-4093-832X)
- Jun Hyuk Hong (ORCID: https://orcid.org/0000-0003-2705-0481)
- Jung Kwon Kim (ORCID: https://orcid.org/0000-0002-8069-6225)
- Hanjong Ahn (ORCID: https://orcid.org/0000-0001-7608-5352)
- Sangmin Lee (ORCID: https://orcid.org/0000-0002-3457-0816)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Prostate International
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1016/j.prnil.2024.10.002
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.84